GENinCode
GENI · AIM · Health Care · mcap £4.9m · 0.6p
Financials · LTM to 30 Jun 26
Source: results 29 Sep 26 ↗
- Revenue
- £2.6m
- Operating profit
- −£5.5m
- Net income
- −£5.3m
- Free cash flow
- −£4.1m
- Net cash
- £2.0m
- Market cap
- £1.8m
- EV / EBIT
- –
- FCF yield
- −228.4%
- Price / book
- 0.9×
Latest half-year · H1 26 vs H1 25
results 29 Sep 26 ↗
- Revenue
- £1.1m −30%
- Operating profit
- −£2.5m prior −£3.0m
- Net income
- −£2.5m prior −£3.0m
- Cash from operations
- −£3.1m prior −£3.2m
Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.
Latest report: H1 26 (six months to 30 Jun 26), published 29 Sep 26 · read the results ↗
£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source
| LTM Jun 26 | FY 25 | FY 24 | |
|---|---|---|---|
| Revenue | 2.6 | 3.1 | 2.7 |
| Gross profit | 1.5 | 1.8 | 1.4 |
| Adjusted EBITDA | (4.6) | (4.9) | (4.4) |
| Operating profit | (5.5) | (5.9) | (5.1) |
| Depreciation (owned assets) | (0.1) | (0.2) | – |
| Amortisation | (0.1) | (0.1) | (0.1) |
| Share-based payments | (0.7) | (0.8) | (0.4) |
| Finance costs | 0.0 | (0.0) | (0.0) |
| Profit before tax | (5.4) | (5.9) | (5.1) |
| Tax | 0.2 | 0.2 | 0.6 |
| Net income (owners) | (5.3) | (5.7) | (4.4) |
| EPS basic | (1.3p) | (2.1p) | (2.5p) |
| EPS diluted | (1.3p) | (2.1p) | (2.5p) |
| H1 26 | vs H1 25 | H2 25 | H1 25 | |
|---|---|---|---|---|
| Revenue | 1.1 | −30% | 1.5 | 1.6 |
| Gross profit | 0.5 | −37% | 1.0 | 0.8 |
| Adjusted EBITDA | (2.3) | n/m | (2.3) | (2.5) |
| Operating profit | (2.5) | n/m | (2.9) | (3.0) |
| Depreciation (owned assets) | (0.0) | −90% | (0.1) | (0.1) |
| Amortisation | (0.1) | n/m | (0.1) | (0.1) |
| Share-based payments | (0.2) | −19% | (0.5) | (0.3) |
| Finance costs | (0.0) | n/m | 0.0 | (0.0) |
| Profit before tax | (2.5) | n/m | (2.9) | (3.0) |
| Tax | 0.0 | n/m | 0.2 | 0.0 |
| Net income (owners) | (2.5) | n/m | (2.7) | (3.0) |
| EPS basic | (0.4p) | – | (0.9p) | (1.2p) |
| EPS diluted | (0.4p) | – | (0.9p) | (1.2p) |
| Latest Jun 26 | FY 25 | FY 24 | |
|---|---|---|---|
| Other intangibles | 0.1 | 0.1 | 0.1 |
| Property, plant & equipment | 0.1 | 0.1 | 0.2 |
| Other investments | – | 0.1 | 0.1 |
| Inventories | 0.1 | 0.1 | 0.1 |
| Trade receivables | 1.1 | 1.1 | 0.8 |
| Cash | 2.0 | 0.8 | 1.1 |
| Current assets | 3.3 | 2.0 | 2.1 |
| Total assets | 3.5 | 2.4 | 2.7 |
| Trade payables | 1.4 | 2.1 | 1.3 |
| Lease liabilities, current | 0.1 | 0.1 | 0.1 |
| Lease liabilities, non-current | 0.0 | 0.1 | 0.1 |
| Total liabilities | 1.5 | 2.3 | 1.5 |
| Total equity | 2.1 | 0.1 | 1.1 |
| Shares in issue | 753.0m | – | – |
| H1 26 | H2 25 | H1 25 | H2 24 | |
|---|---|---|---|---|
| Other intangibles | 0.1 | 0.1 | 0.1 | 0.1 |
| Property, plant & equipment | 0.1 | 0.1 | 0.1 | 0.2 |
| Other investments | – | 0.1 | – | 0.1 |
| Inventories | 0.1 | 0.1 | 0.1 | 0.1 |
| Trade receivables | 1.1 | 1.1 | 1.2 | 0.8 |
| Cash | 2.0 | 0.8 | 2.4 | 1.1 |
| Current assets | 3.3 | 2.0 | 3.8 | 2.1 |
| Total assets | 3.5 | 2.4 | 4.2 | 2.7 |
| Trade payables | 1.4 | 2.1 | 1.4 | 1.3 |
| Lease liabilities, current | 0.1 | 0.1 | 0.0 | 0.1 |
| Lease liabilities, non-current | 0.0 | 0.1 | 0.2 | 0.1 |
| Total liabilities | 1.5 | 2.3 | 1.6 | 1.5 |
| Total equity | 2.1 | 0.1 | 2.7 | 1.1 |
| Shares in issue | 753.0m | – | – | – |
Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.
Company filings. Not investment advice.